Clinical trial · Observational
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
NCT06375941CI-TRIAL-00097588ProStarsrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will be a multi-institutional, prospective, observational study of patients with localized primary AS of any site within ISG and RTR centers. Patients will be treated according to clinical practice of the center and according to ISG clinical recommendations on localized AS.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Angiosarcoma | Angiosarcoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observational | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Pathological diagnosis of AS, any site of origin, any age, primary, localized, resectable disease.
- description
- * pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease.
- interventionNames
- Other: Observational
Primary outcomes (10)
- measure
- Demographic characteristics
- timeFrame
- At the time of enrollment
- description
- Demographic data
- measure
- General characteristics
- timeFrame
- At the time of enrollment
- description
- Comorbidities
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * pathological diagnosis of AS; * any site of origin; * any age; * primary, localized, resectable disease. Exclusion Criteria: NA
References
Publications (0)
Data not yet available
No reference posted for this study.